Back to Search
Start Over
Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg).
- Source :
-
Journal of neuro-oncology [J Neurooncol] 2016 Sep; Vol. 129 (3), pp. 579-581. Date of Electronic Publication: 2016 Jul 18. - Publication Year :
- 2016
- Subjects :
- Adolescent
Adult
Aged
Argininosuccinate Lyase metabolism
Brain Neoplasms drug therapy
Brain Neoplasms metabolism
Cell Line, Tumor
Cell Proliferation
Child
Child, Preschool
Glioblastoma drug therapy
Glioblastoma metabolism
Humans
Middle Aged
Polyethylene Glycols chemistry
Prognosis
Survival Rate
Young Adult
Arginine metabolism
Argininosuccinate Synthase metabolism
Biomarkers, Tumor metabolism
Brain Neoplasms pathology
Glioblastoma pathology
Ornithine Carbamoyltransferase metabolism
Recombinant Proteins therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1573-7373
- Volume :
- 129
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Journal of neuro-oncology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 27431689
- Full Text :
- https://doi.org/10.1007/s11060-016-2209-7